These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
353 related items for PubMed ID: 11103776
1. TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers. Conway KE, McConnell BB, Bowring CE, Donald CD, Warren ST, Vertino PM. Cancer Res; 2000 Nov 15; 60(22):6236-42. PubMed ID: 11103776 [Abstract] [Full Text] [Related]
3. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Robert MF, Morin S, Beaulieu N, Gauthier F, Chute IC, Barsalou A, MacLeod AR. Nat Genet; 2003 Jan 15; 33(1):61-5. PubMed ID: 12496760 [Abstract] [Full Text] [Related]
4. Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer. Virmani A, Rathi A, Sugio K, Sathyanarayana UG, Toyooka S, Kischel FC, Tonk V, Padar A, Takahashi T, Roth JA, Euhus DM, Minna JD, Gazdar AF. Int J Cancer; 2003 Aug 20; 106(2):198-204. PubMed ID: 12800194 [Abstract] [Full Text] [Related]
5. Activation of a caspase-9-mediated apoptotic pathway by subcellular redistribution of the novel caspase recruitment domain protein TMS1. McConnell BB, Vertino PM. Cancer Res; 2000 Nov 15; 60(22):6243-7. PubMed ID: 11103777 [Abstract] [Full Text] [Related]
6. Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer. Ai L, Tao Q, Zhong S, Fields CR, Kim WJ, Lee MW, Cui Y, Brown KD, Robertson KD. Carcinogenesis; 2006 Jul 15; 27(7):1341-8. PubMed ID: 16501252 [Abstract] [Full Text] [Related]
8. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, Issa JP, Bast RC, Yu Y. Cancer Res; 2003 Jul 15; 63(14):4174-80. PubMed ID: 12874023 [Abstract] [Full Text] [Related]
9. Methylation mediated silencing of TMS1/ASC gene in prostate cancer. Das PM, Ramachandran K, Vanwert J, Ferdinand L, Gopisetty G, Reis IM, Singal R. Mol Cancer; 2006 Jul 18; 5():28. PubMed ID: 16848908 [Abstract] [Full Text] [Related]
10. Methylation-mediated silencing of TMS1/ASC is accompanied by histone hypoacetylation and CpG island-localized changes in chromatin architecture. Stimson KM, Vertino PM. J Biol Chem; 2002 Feb 15; 277(7):4951-8. PubMed ID: 11733524 [Abstract] [Full Text] [Related]
11. A proapoptotic caspase recruitment domain protein gene, TMS1, is hypermethylated in human breast and gastric cancers. Moriai R, Tsuji N, Kobayashi D, Yagihashi A, Namiki Y, Takahashi H, Watanabe N. Anticancer Res; 2002 Feb 15; 22(6C):4163-8. PubMed ID: 12553049 [Abstract] [Full Text] [Related]
12. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma. Sathyanarayana UG, Padar A, Huang CX, Suzuki M, Shigematsu H, Bekele BN, Gazdar AF. Clin Cancer Res; 2003 Dec 15; 9(17):6389-94. PubMed ID: 14695139 [Abstract] [Full Text] [Related]
13. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide. Lin X, Asgari K, Putzi MJ, Gage WR, Yu X, Cornblatt BS, Kumar A, Piantadosi S, DeWeese TL, De Marzo AM, Nelson WG. Cancer Res; 2001 Dec 15; 61(24):8611-6. PubMed ID: 11751372 [Abstract] [Full Text] [Related]
15. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning. Hinshelwood RA, Melki JR, Huschtscha LI, Paul C, Song JZ, Stirzaker C, Reddel RR, Clark SJ. Hum Mol Genet; 2009 Aug 15; 18(16):3098-109. PubMed ID: 19477956 [Abstract] [Full Text] [Related]